《骨髓增殖性腫瘤》PPT課件

《骨髓增殖性腫瘤》PPT課件

ID:39202883

大?。?25.31 KB

頁(yè)數(shù):26頁(yè)

時(shí)間:2019-06-27

《骨髓增殖性腫瘤》PPT課件_第1頁(yè)
《骨髓增殖性腫瘤》PPT課件_第2頁(yè)
《骨髓增殖性腫瘤》PPT課件_第3頁(yè)
《骨髓增殖性腫瘤》PPT課件_第4頁(yè)
《骨髓增殖性腫瘤》PPT課件_第5頁(yè)
資源描述:

《《骨髓增殖性腫瘤》PPT課件》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在教育資源-天天文庫(kù)。

1、HongzhiXuShandongProvincialHospitalMyeloproliferativeDisordersCONTENTSPathogenesisandmanagementofessentialthrombocythemiaIdiopathicerythrocytosis:adisappearingentityTherapeuticpotentialofJAK2inhibitorsPathogenesisandmanagementofessentialthrombocythemiaPathogenesisRelations

2、hipofETtoPVandPMFThelevelofJAK2-STAT5signalingprovidesarheostatthatdetermineswhetherthediseasephenotypeispredominantlyerythroidormegakaryocytic.Severallinesofevidencesuggestablurringofthedistinctionbetweenthesedisorders.AproporationofpatientsdiagnosedwithET(seeTable1forcri

3、teria)harborincreasedlevelsofbonemarrowreticulinintheabsenceofotherfeaturessuggestingadiagnosisofPMFThevariabledegreeofreticulinaccumulationreflectsthecombinedeffectsofgeneticbackground,diseaseduration,therapy,clonalburdenandtheacquisitionofadditionalgeneticlesions.Table1.

4、Suggesteddiagnosticcriteriaforessentialthrombocythemia(ET)DiagnosisrequiresA1-A3ORA1+A3-A5A1Sustainedplateletcount>450X109/L.A2Presenceofanacquiredpathogeneticmutation(eg,inJAK2orMPL).A3Noothermyeloidmalignancy,especiallypolycythemiavera(PV),primarymyelofibrosis(PMF),chron

5、icmyeloidleukemia(CML)ormyelodysplasticsyndrome(MDS).A4Noreactivecauseforthrombocytosisandnormalironstores.A5Bonemarrowtrephinehistologyshowingincreasedmegakaryocyteswithprominentlargehyperlobatedforms;reticulinisgenerallynotincreased(≤2ona0-4scale).FamilialPredispositiont

6、oETandOtherMyeloproliferativeNeoplasmsArelativeriskof7.4fordevelopingETinthosewithanaffectedfirst-degreerelative.AreMutationsinJAK2Disease-initiatingEvents?TheacquisitionofaJAK2mutationwasprecededbyeitheradeletionofchromosome20q24oramutationinTET2.Directevidencenowexistsde

7、monstratingthatJAK2mutationsarenotthedisease-initiatingeventinsomepatients,althoughthefrequencyofthisscenarioremainsunclear.ProgressiontoAcuteMyeloidLeukemiaProgressiontoacutemyeloidleukemia(AML)occursinasmallminorityofETpatientsandinvolvestheaccrualoffurthergeneticevents.

8、DiagnosisandManagementDiagnosticCriteriaMutationsinJAK2exon12arenotthoughttooccurinpatien

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動(dòng)畫(huà)的文件,查看預(yù)覽時(shí)可能會(huì)顯示錯(cuò)亂或異常,文件下載后無(wú)此問(wèn)題,請(qǐng)放心下載。
2. 本文檔由用戶(hù)上傳,版權(quán)歸屬用戶(hù),天天文庫(kù)負(fù)責(zé)整理代發(fā)布。如果您對(duì)本文檔版權(quán)有爭(zhēng)議請(qǐng)及時(shí)聯(lián)系客服。
3. 下載前請(qǐng)仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動(dòng)等原因無(wú)法下載或下載錯(cuò)誤,付費(fèi)完成后未能成功下載的用戶(hù)請(qǐng)聯(lián)系客服處理。